Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Reilly
Thomas B
TB
Department of Surgery, Morehouse School of Medicine, Emory University Hospital, Atlanta, GA 30310, USA. treilly@msm.edu
Schuster
David M
DM
Starsiak
Michael D
MD
Kost
Christine B
CB
Halkar
Raghuveer K
RK
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008206:Lymphatic Diseases / Q000139:chemically induced* / Q000175:diagnosis*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D019275:Radiopharmaceuticals; D000069283:Rituximab; D012507:Sarcoidosis / Q000139:chemically induced* / Q000175:diagnosis*; D013154:Spleen / Q000000981:diagnostic imaging / Q000187:drug effects; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone